STORTO, GIOVANNI
 Distribuzione geografica
Continente #
AS - Asia 1.572
NA - Nord America 1.148
EU - Europa 356
SA - Sud America 256
Continente sconosciuto - Info sul continente non disponibili 29
AF - Africa 27
OC - Oceania 2
Totale 3.390
Nazione #
US - Stati Uniti d'America 1.084
SG - Singapore 635
CN - Cina 379
BR - Brasile 196
VN - Vietnam 152
HK - Hong Kong 143
IT - Italia 102
FR - Francia 92
BD - Bangladesh 87
KR - Corea 72
NL - Olanda 43
DE - Germania 34
CA - Canada 31
GB - Regno Unito 31
IN - India 23
AR - Argentina 17
JP - Giappone 17
MX - Messico 15
CO - Colombia 13
EC - Ecuador 12
ID - Indonesia 11
FI - Finlandia 10
IQ - Iraq 10
ES - Italia 8
ZA - Sudafrica 8
IL - Israele 7
JM - Giamaica 6
SA - Arabia Saudita 6
UA - Ucraina 6
CL - Cile 5
MA - Marocco 5
RU - Federazione Russa 5
TR - Turchia 5
PH - Filippine 4
SE - Svezia 4
VE - Venezuela 4
CH - Svizzera 3
CR - Costa Rica 3
DK - Danimarca 3
EG - Egitto 3
HN - Honduras 3
IE - Irlanda 3
MY - Malesia 3
PY - Paraguay 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
GY - Guiana 2
JO - Giordania 2
KE - Kenya 2
KG - Kirghizistan 2
LT - Lituania 2
OM - Oman 2
PE - Perù 2
PK - Pakistan 2
PL - Polonia 2
RO - Romania 2
UY - Uruguay 2
UZ - Uzbekistan 2
AO - Angola 1
AW - Aruba 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BI - Burundi 1
CI - Costa d'Avorio 1
ET - Etiopia 1
GT - Guatemala 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LV - Lettonia 1
LY - Libia 1
MN - Mongolia 1
NI - Nicaragua 1
NP - Nepal 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SZ - Regno dello Swaziland 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
ZW - Zimbabwe 1
Totale 3.361
Città #
Singapore 419
Santa Clara 384
Hefei 164
Hong Kong 141
San Jose 132
Beijing 74
Ashburn 73
Seoul 72
Lauterbourg 63
Ho Chi Minh City 51
Hanoi 48
New York 39
Los Angeles 37
Frankfurt am Main 17
Buffalo 15
Dallas 15
Chicago 13
São Paulo 13
Toronto 11
Naples 10
Atlanta 9
Montreal 9
Rome 9
Milan 8
Minamishinagawa 8
Phoenix 8
Tokyo 8
Brasília 7
Council Bluffs 7
Haiphong 7
Helsinki 7
Portsmouth 7
Rio de Janeiro 7
Suzhou 7
Denver 6
London 6
Palermo 6
Guangzhou 5
Guayaquil 5
Johannesburg 5
Louisville 5
Manaus 5
Orem 5
Quito 5
Afragola 4
Baghdad 4
Bologna 4
Boston 4
Charlotte 4
Chennai 4
Da Nang 4
Düsseldorf 4
Houston 4
Philadelphia 4
Queens 4
Washington 4
Amsterdam 3
Arlington 3
Bauru 3
Bogotá 3
Buenos Aires 3
Curitiba 3
Dhaka 3
Dublin 3
Duque de Caxias 3
El Paso 3
Guarulhos 3
Hải Dương 3
Jackson 3
Kingston 3
Memphis 3
Mexico City 3
Nuremberg 3
Pittsburgh 3
Ponta Grossa 3
Porto Alegre 3
Quảng Ngãi 3
San Antonio 3
San Francisco 3
Shanghai 3
Stockholm 3
São José dos Campos 3
The Bronx 3
Vũng Tàu 3
Zhenjiang 3
Amman 2
Bagé 2
Belo Horizonte 2
Bengaluru 2
Berlin 2
Bexley 2
Bishkek 2
Biên Hòa 2
Brooklyn 2
Brownsville 2
Cagliari 2
Cairo 2
Camaçari 2
Cambridge 2
Can Tho 2
Totale 2.117
Nome #
F-18 FDG PET/CT in the assessment of patients with unexplained CEA rise after surgical curative resection for colorectal cancer 120
F-18 FDG PET/CT metabolic tumor volume predicts overall survival in patients with disseminated epithelial ovarian cancer 105
F-18 FDG PET/CT and F-18 FLT PET/CT as predictors of outcome in patients with multiple myeloma. A pilot study 102
F-18 FDG PET/CT quantization parameters as predictors of outcome in patients with diffuse large B-cell lymphoma 101
Diffusion volume (DV) measurement in endometrial and cervical cancer: A new MRI parameter in the evaluation of the tumor grading and the risk classification 88
Estimate of the accelerated proliferation by protein tyrosine phosphatase (PTEN) over expression in postoperative radiotherapy of head and neck squamous cell carcinoma. 83
THE IMPACT ON THE ENVIRONMENT AND ON THE POPULATION DUE TO THE RELEASE OF THE PATIENTS AFTER THERAPY WITH UNSEALED SOURCES: A COMPARISON BETWEEN THE NEW INTERNATIONAL RECOMMENDATIONS AND THE ITALIAN REGULATIONS 82
[F-18]FDG-PET-CT for early monitoring of tumor response: when and why 80
Critical dose and toxicity index of organs at risk in radiotherapy: Analyzing the calculated effects of modified dose fractionation in non-small cell lung cancer 77
Prognostic role of 18F-FDG PET/CT in the postoperative evaluation of differentiated thyroid cancer patients 73
Clinical radiobiology of glioblastoma multiforme Estimation of tumor control probability from various radiotherapy fractionation schemes 72
Combined therapy of Sr-89 and zoledronic acid in patients with painful bone metastases 70
Ga-68-Edotreotide Positron Emission Tomography/Computed Tomography Somatostatin Receptors Tumor Volume Predicts Outcome in Patients With Primary Gastroenteropancreatic Neuroendocrine Tumors 69
Accreditation for excellence of cancer research institutes: recommendations from the Italian Network of Comprehensive Cancer Centers. 68
Assessment of psychological status by a comprehensive approach in thyroid cancer patients undergoing radionuclide therapy: A feasibility study 67
Quantitative Assessment of Myocardial Blood Flow with SPECT 65
Relationship between brachial artery flow-mediated dilation and coronary flow reserve in patients with peripheral artery disease 63
Estimation of coronary flow reserve by sestamibi imaging in patients with mild hypertension and normal coronary arteries. 58
Impaired coronary microvascular function in patients with chest pain and normal coronary arteries 57
Challenging Axillary Lymph Nodes on PET/CT in Cancer Patients throughout COVID-19 Vaccination Era 55
Impact of (18)F-fluoride PET-CT on implementing early treatment of painful bone metastases with Sm-153 EDTMP 55
MRI findings of a remote and isolated vaginal metastasis revealing an adenocarcinoma of the mid-sigmoid colon 54
Therapeutic Strategies in HCC: Radiation Modalities 51
Enhancement of reaction conditions for the radiolabelling of DOTA-peptides with high activities of yttrium-90 51
Correlation between EGFr expression and accelerated proliferation during radiotherapy of head and neck squamous cell carcinoma. 50
Radium-223 for the treatment of bone metastases in castration-resistant prostate cancer: when and why 49
Palliative treatment of bone metastases with samarium-153 EDTMP at onset of pain 49
THE IMPACT ON THE ENVIRONMENT AND ON THE POPULATION DUE TO THE RELEASE OF THE PATIENTS AFTER THERAPY WITH UNSEALED SOURCES: A COMPARISON BETWEEN THE NEW INTERNATIONAL RECOMMENDATIONS AND THE ITALIAN REGULATIONS 47
Assessment of Metabolic Response to Radioimmunotherapy with Y-90-Ibritumomab Tiuxetan in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma 45
The intriguing issue of genetic predisposition and the importance of identification of pre-clinical markers of endothelial damage in radiotherapy-induced cardiotoxicity 45
ACTIVITY THRESHOLD DETERMINING CUMULATIVE ADERSE-EFFECTS IN PATIENTS UNDERGOING PEPTIDE RECEPTOR RADIONUCLIDE THERAPY WITH Y-90 OCTREOTATE. 44
Cardiac performance during exercise in hypertensive patients without ventricular hypertrophy 43
Usefulness of [111In-DTPA0] octreotide scintigraphy in a family with von Hippel-Lindau disease. 43
Should patients with remnants from thyroid microcarcinoma really not be treated with iodine-131 ablation? 43
Usefulness of [In-111-DTPA(0)] octreotide scintigraphy in a family with von Hippel-Lindau disease 42
HOW MUCH 18FDG IS NEEDED TO SCAN A GIVEN NUMBER OF ONCOLOGIC PATIENTS WITH PET/CT? 40
Colorectal cancer: Parametric evaluation of morphological, functional and molecular tomographic imaging 40
Short term outcome of differentiated thyroid cancer patients receiving a second iodine-131 therapy on the basis of a detectable serum thyroglobulin level after initial treatment. 36
Assessment of coronary flow reserve by sestamibi imaging in patients with typical chest pain and normal coronary arteries. 36
Assessment of the arterial input function for estimation of coronary flow reserve by single photon emission computed tomography: comparison of two different approaches 35
Assessment of the arterial input function for the estimation of coronary flow reserve by SPECT imaging: comparison of two different methods 35
Colorectal cancer and 18FDG-PET/CT: What about adding the T to the N parameter in loco-regional staging? 34
Prediction of improvement in global left ventricular function in patients with chronic coronary artery disease and impaired left ventricular function: rest thallium-201 SPET versus low-dose dobutamine echocardiography. 33
Effects of valsartan on left ventricular diastolic function in patients with mild or moderate essential hypertension: comparison with enalapril. 32
Influence of risk factors on coronary flow reserve in patients with 1-vessel coronary artery disease 32
Combined therapy of Sr-89 and zoledronic acid in patients with painful bone metastases 32
Hemodynamic determinants of exercise-induced abnormal blood pressure response in hypertrophic cardiomyopathy 32
Assessment of coronary flow reserve using single photon emission computed tomography with technetium 99m-labeled tracers 31
Relation between wall thickening on gated perfusion SPECT and functional recovery after coronary revascularization in patients with previous myocardial infarction. 31
Assessment of coronary flow reserve by sestamibi imaging in patients with typical chest pain and normal coronary arteries (vol 34, pg 1156, 2007) 31
Relations of left ventricular mass and systolic function to endothelial function and coronary flow reserve in healthy, new discovered hypertensive subjects 30
Fluorodeoxyglucose PET/CT in patients with differentiated thyroid cancer and elevated thyroglobulin after total thyroidectomy and I-131 ablation 30
Assessment of Metabolic Response to Radioimmunotherapy with Y-90-Ibritumomab Tiuxetan in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma 30
Modelling the correlation between EGFr expression and tumour cell radiosensitivity, and combined treatments of radiation and monoclonal antibody EGFr inhibitors 30
Early and late effects of coronary artery bypass grafting on cardiac haemodynamics during daily physical activities in patients with coronary artery disease. 29
RADIONUCLIDE THERAPY 29
Estimation of coronary flow reserve by Tc-99m sestamibi imaging in patients with coronary artery disease: Comparison with the results of intracoronary Doppler technique 28
Comparison of hemodynamic adaptation to orthostatic stress in patients with hypertrophic cardiomyopathy with or without syncope and in vasovagal syncope. 28
Assessment of coronary vascular function by sestamibi imaging in patients with diabetes and normal coronary arteries 28
Noninvasive quantification of coronary endothelial function by SPECT imaging in children with a history of Kawasaki disease. 27
Radionuclide monitoring of left ventricular function. 27
Assessment of the arterial input function for estimation of coronary flow reserve by single photon emission computed tomography: comparison of two different approaches 27
Estimation of coronary flow reserve by sestamibi imaging in type 2 diabetic patients with normal coronary arteries. 27
Effects left ventricle asynchrony on systolic and diastolic function in patients with non-ischemic heart failure 26
Incremental prognostic value of coronary flow reserve assessed with single-photon emission computed tomography 26
Biokinetics of a F(ab')3 iodine-131 labeled antigen binding construct (Mab 35) directed against CEA in patients with colorectal carcinoma. 26
Prediction of long-term effects of revascularization on regional and global left ventricular function by dobutamine echocardiography and rest Tl-201 imaging alone and in combination in patients with chronic coronary artery disease 25
Relationship between brachial artery flow-mediated dilation and coronary flow reserve in patients with peripherals artery disease 25
Diagnostic accuracy of low-dose dobutamine echocardiography in predicting post-revascularisation recovery of function in patients with chronic coronary artery disease: relationship to thallium-201 uptake. 24
Assessment of metabolic activity by PET-CT with F-18-FDG in patients with T-cell lymphoma 24
Postsurgical diagnostic evaluation of patients with differentiated thyroid carcinoma: comparison of ultrasound iodine-131 scintigraphy and PET with fluorine-18 fluorodeoxyglucose 23
Local tumor control probability to evaluate an applicator-guided volumetric-modulated arc therapy solution as alternative of 3D brachytherapy for the treatment of the vaginal vault in patients affected by gynecological cancer 23
The clinical impact of a cardiologic follow-up in breast cancer survivors: an observational study. 22
Totale 3.390
Categoria #
all - tutte 10.799
article - articoli 9.619
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 112
Totale 20.530


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202418 0 0 0 0 0 0 0 1 4 0 13 0
2024/20251.173 6 7 108 48 369 25 10 23 19 71 275 212
2025/20261.864 80 180 152 218 326 79 293 64 101 108 163 100
2026/2027335 94 68 173 0 0 0 0 0 0 0 0 0
Totale 3.390